LysoPE(0:0/20:1)
|
Basic information |
| Metabolite name | LysoPE(0:0/20:1) |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | LysoPE(0:0/20:1) |
| N/A |
|
N/A |
|
N/A |
| Synonyms | NA |
| No. of studies | 4 |
|
Relationship between LysoPE(0:0/20:1) and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M104 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M104 | Type2 | CUMS + BH group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M104 | Type2 | CUMS + fluoxetine group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M582 | Type1 | CUMS group vs. control group | Serum | C57BL/6N mouse | Down |
| Study M582 | Type2 | CUMS + fluoxetine group vs. CUMS group | Faece | C57BL/6N mouse | Down |
| Study M582 | Type3 | control + fluoxetine group vs. control group | Faece | C57BL/6N mouse | Down |
| Study M743 | Type1 | CUS group vs. control group | Plasma | Sprague-Dawley rat | Down |